Singapore Pharmaceutical Market Outlook 2024: Opportunity Assessment And Demand Analysis, Market Forecast, 2016-2024

About This Presentation
Title:

Singapore Pharmaceutical Market Outlook 2024: Opportunity Assessment And Demand Analysis, Market Forecast, 2016-2024

Description:

Singapore pharmaceutical market is anticipated to grow at a CAGR of 6.40% during the forecast period. Singapore medical device market is estimated to reach over USD 530 million by 2024. – PowerPoint PPT presentation

Number of Views:6
Slides: 15
Provided by: steveblade

less

Transcript and Presenter's Notes

Title: Singapore Pharmaceutical Market Outlook 2024: Opportunity Assessment And Demand Analysis, Market Forecast, 2016-2024


1
Singapore Pharmaceutical Market Outlook 2024
Report Code HC 1238
2016-2024
1-646-568-7747
1-437-886-1181
44-203-318-6627
91-120-473-0422, 91-844-785-9968
sales_at_goldsteinresearch.com
2
Executive Summary
Global Pharmaceutical Market Share(), By
Region-2016-2024
Singapore Pharmaceutical Market Size USD
(Billion). 2016-2024
Sample
Source Goldstein Research
Source Goldstein Research
In 2016, Over the counter drugs accounted for the
highest market share XX in Singapore
Pharmaceutical Market
With XX share in 2016, North America region
dominated the collective Singapore Pharmaceutical
Market
Singapore Pharmaceutical Market Share(), By
Therapeutics-2016
Singapore Pharmaceutical Market Share(), By
Product Type-2016
Percentage of GDP Spent on Health Care, 2014
4.9
Source Goldstein Research
Source Goldstein Research
Copyright All Rights Reserved, Goldstein
Research www.goldsteinresearch.com
3
Presence of Major Players
Increasing geriatric population
Sample
Increase in Obese Population
Singapore
Indonesia
Rising adoption of strong public health policies
2016
USD XX Billion
USD XX Billion
2024
USD XX Billion
USD XX Billion
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
4
Top Global Pharmaceutical Markets And The
Competitive Landscape
Sample Report
Sample
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
5
Singapore
Pharmaceutical Market Size Growth Analysis
Singapore Pharmaceutical Market Size (USD
Billion)-2016-2024
Singapore Pharmaceutical Market Y-O-Y Growth ()
Analysis-2016-2024
Sample
Source Goldstein Research
Source Goldstein Research
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
6
Singapore Pharmaceutical Market Overview, By
Region and Market Players-2016
Top Six Health Issues In Singapore, 2016
World Top Pharmaceutical Companies Market Share
(), By Players, 2016
Sample
Source Goldstein Research
Source Goldstein Research
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
7
Market Dynamics of Singapore Pharmaceutical
Market
Growth Drivers
Growth Barriers
Sample
General Trend
Sample Report
Highly Complex
Moderately Complex
Waived
Dynamics
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
8
Growth Drivers
  • Growth in aging population
  • Rise in aging population in many nations across
    the globe is a major a growth driver for the
    pharmaceutical industry.
  • This aging population is expected to have
    diabetic and other health related problems in
    Singapore as XX of the total population are
    obese in Singapore which further increases the
    risk of diabetes and heart related problems.
  • Rising concern towards fitness healthy
    lifestyle among aging population is expected to
    spike the healthcare industry in near future.
  • In Singapore, XX million people are aged above 65
    in 20105 i.e. XX of the total population this
    aging population is expected to reach XX of the
    total population by 2030 according to the report
    of Centers for Disease Control Prevention (CDS)

Fig 5-1 Population(Million), Aging
population(Million), Singapore-2016-2050
Singapore Population
Sample
2016
2050
XX Million
XX Million
Aging population
2016
2050
XX Million
XX Million
Source World Bank
  • Impact Analysis-
  • Government funding for the advancement in
    healthcare sector and initiatives to promote
    healthcare across the globe is expected to
    positively impact on the growth of Singapore
    pharmaceuticals market.
  • Increase in aging population and focusing on
    fitness healthy lifestyle is predicted to rise
    the Singapore pharmaceuticals market.

Singapores Mundipharma acquires brands as part
of Thai growth push and this deal was cracked at
USD XX Billion
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
9
Age-standardized Prevalence Of Chronic Issues In
Adults 20 Years And Older By World Region And
Sex, 2015 2016
2015
Sample
Prevalence of Chronic Disorders
2016
Copyright All Rights Reserved, Goldstein
Research www.goldsteinresearch.com
10
Why Singapore Is A Pharma Hub for Asia?
Over the past ten years, Singapore has evolved
into a pharmaceutical and medical technology hub
due to its world-class infrastructure,
highly-skilled biomedical workforce and favorable
government policy initiatives. Over 30 of the
worlds top pharmaceutical and medical technology
firms have established their manufacturing, RD
and headquarter functions in Singapore to
identify new strategic business opportunities,
and accelerate product innovation in Asia. These
include Abbott, GlaxoSmithKline, Lonza, MSD,
Novartis, Pfizer and Sanofi-Aventis.
Sample
The pharmaceutical market in Singapore is set to
rise from USD XX million in 2017 to around USD XX
billion in 2024, and will first exceed the USD XX
billion mark in 2019
With a population of only 5.6 million as of 2016,
Singapore provides limited scope for domestic
businesses to generate revenue. However, the
country is a regional hub, and provides
world-class infrastructure for manufacturing and
RD facilities of multinational pharmaceutical
companies.
The pharmaceutical industry in Singapore
experienced a number of large scale mergers and
acquisitions (MA) over the past several years.
Most recently, GlaxoSmithKline (GSK) and Novartis
combined their Consumer Healthcare businesses to
create a new joint venture in Singapore. GSK will
also establish its global Asia headquarters in
Singapore to oversee the Pharmaceuticals,
Vaccines and Consumer Healthcare businesses in
Asia. As a result, almost 150 global or regional
roles moved to Singapore in the last year.
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
11
About Us Based in U.S., Goldstein Research is
a young business consulting and market research
firm with vast reach across America, Asia and
parts of Europe and the Middle East. In the next
five years, we strive to expand our reach to 50
nations spanning across Europe, Asia and parts of
the Middle East and Africa. We strive to realize
a strong brand presence globally through our
quality research and forecasting solutions. With
30 domain experts and 50 employees working day
and night to crunch numbers and bring out the
best and detailed market reports and forecasts,
we strive to enable you to foresee upcoming
market challenges and develop a robust business
model and strategies, which would add to your
profitability and market visibility as a
brand. Our mission is simple to develop
insightful business solutions, help our clients
make powerful future decisions to keep them well
ahead of the game which is the market, and leave
a mark across businesses and communities through
our well-defined ideas and clear cut forecasts.
Our mission is simple to develop insightful
business solutions, help our clients make
powerful future decisions to keep them well ahead
of the game which is the market, and leave a mark
across businesses and communities through our
well-defined ideas and clear cut forecasts.
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
12
Terms of Use Kindly note that the publications
made by Goldstein Research are exclusively
proprietary. The market information revealed is
subjected to the approval with an appropriate
e-mail requested to Goldstein Research. Initial
data and content can be published with a written
permission of Goldstein Research. Further, to be
noted that no part of our strategic business
quantitative or qualitative data or analysis
should be used for general purpose. Its a non
-disclosure and not for public disclosure. Accurac
y of the data are solely contingent to the
primary interview conducted and it may result in
mare variations. So, we do not take
responsibility however the data and the
information provided are at our utmost
precision. Kindly note Any lending, disclosure,
resale, or copying of this publication can only
be prepared with preceding written approval from
Goldstein Research. Photocopying, mechanical,
electronic, recording or otherwise are strictly
prohibited deprived of permission from Goldstein
Research. Also, transmission of this document by
any means or in any form are still strictly
forbidden.
Published By Goldstein Research
Copyright All Rights Reserved, Goldstein
Research
www.goldsteinresearch.com
13
Contact Us For Research Sales Related Queries
Corporate Office
99 Wall Street, Suite No- 527, New York, NY
10005 United States of America
Office No- 504, 5th Floor, C-51, BSI Business
Park, Sector-62, Noida, PIN- 201301 India 
www.goldsteinresearch.com
14
Thank you
Connect With Us
Published By Goldstein Research
Write a Comment
User Comments (0)